NB001 for treating acute migraine attacks
Part of Brain & nervous system clinical trials.
This study tests a new medication called NB001 to help stop migraine headaches when they happen. Researchers want to see if it works better than current treatments for people who have frequent migraines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have been diagnosed with migraine (with or without aura) and have had migraines for at least 1 year
- You have 2 to 8 moderate or severe migraine attacks per month
- Your untreated migraines typically last 4 to 72 hours
- You are willing to use strict contraception if you can become pregnant
- You can read, understand, and complete study questionnaires using a computer or phone app
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if oral NBP soft capsules can prevent migraine attacks in adults. It compares the drug against a placebo to see if it reduces how often migraines occur.
This trial tests a new medicine, MEDI0618, against a placebo for people with episodic migraine. The goal is to see if MEDI0618 is safe and effective at reducing migraine days.
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
This trial tests if a gentle nasal stimulation device can help prevent migraines. It is for adults with frequent migraines (at least 8 days per month).
This trial tests a substance that activates adrenomedullin receptors, which may be a new way to treat migraines. It may help people who have migraines without aura and aren't on preventive migraine medications.
This study tests a new inhaled powder form of a migraine medication called dihydroergotamine (DHE) to see if it safely and effectively stops migraine attacks. If you have frequent migraines, this trial might offer you a new treatment option to try.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.